Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA-PQ for Seasonal Malaria Chemoprophylaxis in Tanzania
NCT05874869Completed
- Start
- Jul 2020
- Primary completion
- Jun 2021
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of dihydroartemisinin + piperaquine in malaria (2 arms). Primary endpoint: Prevalence of clinical malaria at 12 months. Started Jul 2020; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05874869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05874869.